Sanofi discontinues STAT6 degrader from Nurix two months after entering clinic
The setback hit the biotech's shares even as Cathie Wood's ARK bought the stock.
Read at Fierce Biotech →The setback hit the biotech's shares even as Cathie Wood's ARK bought the stock.
Read at Fierce Biotech →